| 000 | 01618 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515064250.0 | ||
| 264 | 0 | _c20071107 | |
| 008 | 200711s 0 0 eng d | ||
| 022 | _a0166-3542 | ||
| 024 | 7 |
_a10.1016/j.antiviral.2007.03.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKagan, R M | |
| 245 | 0 | 0 |
_aMolecular basis of antagonism between K70E and K65R tenofovir-associated mutations in HIV-1 reverse transcriptase. _h[electronic resource] |
| 260 |
_bAntiviral research _cSep 2007 |
||
| 300 |
_a210-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xmetabolism |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 |
_aDideoxynucleosides _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple, Viral _xgenetics |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Reverse Transcriptase _xchemistry |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLamivudine _xpharmacology |
| 650 | 0 | 4 | _aMutagenesis, Site-Directed |
| 650 | 0 | 4 |
_aOrganophosphonates _xpharmacology |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xmetabolism |
| 650 | 0 | 4 | _aTenofovir |
| 700 | 1 | _aLee, T-S | |
| 700 | 1 | _aRoss, L | |
| 700 | 1 | _aLloyd, R M | |
| 700 | 1 | _aLewinski, M A | |
| 700 | 1 | _aPotts, S J | |
| 773 | 0 |
_tAntiviral research _gvol. 75 _gno. 3 _gp. 210-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.antiviral.2007.03.006 _zAvailable from publisher's website |
| 999 |
_c16992491 _d16992491 |
||